Bhakta S, Mishra P (2021) Molecularly imprinted polymer-based sensors for cancer biomarker detection. Sensors and Actuators Reports 3. https://doi.org/10.1016/j.snr.2021.100061.
Klaassen Z, Arora K, Wilson SN, King SA, Madi R, Neal DE, Kurdyak P, Kulkarni GS, Lewis RW, Terris MK. Decreasing suicide risk among patients with prostate cancer: implications for depression, erectile dysfunction, and suicidal ideation screening. Urologic Oncology: Seminars Orig Invest. 2018;36:60–6.
Rebelo TSCR, Noronha JP, Galésio M, Santos H, Diniz M, Sales MGF, Fernandes MH, Costa-Rodrigues J. Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface. Materials Sci Eng C. 2016;59:1069–78. https://doi.org/10.1016/j.msec.2015.11.032.
Najeeb MA, Ahmad Z, Shakoor RA, Mohamed AMA, Kahraman R. A novel classification of prostate specific antigen (PSA) biosensors based on transducing elements. Talanta. 2017;168:52–61.
Article CAS PubMed Google Scholar
Ertürk G, Hedström M, Tümer MA, Denizli A, Mattiasson B. Real-time prostate-specific antigen detection with prostate-specific antigen imprinted capacitive biosensors. Anal Chim Acta. 2015;891:120–9. https://doi.org/10.1016/j.aca.2015.07.055.
Article CAS PubMed Google Scholar
Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer. 2009;64:92–7. https://doi.org/10.1016/j.lungcan.2008.07.012.
Cui F, Zhou Z, Zhou HS. Review—measurement and analysis of cancer biomarkers based on electrochemical biosensors. J Electrochem Soc. 2020;167:037525. https://doi.org/10.1149/2.0252003jes.
Malhotra R, Patel V, Vaqué JP, Gutkind JS, Rusling JF. Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification. Anal Chem. 2010;82:3118–23. https://doi.org/10.1021/ac902802b.
Article CAS PubMed PubMed Central Google Scholar
Kim DM, Noh HB, Park DS, Ryu SH, Koo JS, Shim YB. Immunosensors for detection of Annexin II and MUC5AC for early diagnosis of lung cancer. Biosens Bioelectron. 2009;25:456–62. https://doi.org/10.1016/j.bios.2009.08.007.
Article CAS PubMed Google Scholar
Mittal S, Kaur H, Gautam N, Mantha AK. Biosensors for breast cancer diagnosis: a review of bioreceptors, biotransducers and signal amplification strategies. Biosens Bioelectron. 2017;88:217–31. https://doi.org/10.1016/j.bios.2016.08.028.
Article CAS PubMed Google Scholar
Prabhakar B, Shende P, Augustine S. Current trends and emerging diagnostic techniques for lung cancer. Biomed Pharmaco. 2018;106:1586–99.
Akgönüllü S, Kılıç S, Esen C, Denizli A (2023) Molecularly imprinted polymer-based sensors for protein detection. Polymers (Basel) 15.
Vasapollo G, Del Sole R, Mergola L, Lazzoi MR, Scardino A, Scorrano S, Mele G. Molecularly imprinted polymers: present and future prospective. Int J Mol Sci. 2011;12:5908–45.
Article CAS PubMed PubMed Central Google Scholar
El-Sharif HF, Turner NW, Reddy SM, Sullivan M V.: Application of thymine-based nucleobase-modified acrylamide as a functional co-monomer in electropolymerised thin-film molecularly imprinted polymer (MIP) for selective protein (haemoglobin) binding. Talanta. 2022;240. https://doi.org/10.1016/j.talanta.2021.123158.
Fresco-Cala B, Batista AD, Cárdenas S.:Molecularly imprinted polymer micro- and nano-particles: a review. Molecules 25;2020.
Altintas Z, Tothill I. Biomarkers and biosensors for the early diagnosis of lung cancer. Sens Actuators B Chem. 2013;188:988–98. https://doi.org/10.1016/j.snb.2013.07.078.
Khan H, Shah MR, Barek J, Malik MI. Cancer biomarkers and their biosensors: A comprehensive review. TrAC - Trends in Analytical Chemistry. 2023;158:116813. https://doi.org/10.1016/j.trac.2022.116813.
Sears CR, Mazzone PJ. Biomarkers in lung cancer. Clin Chest Med. 2020;41:115–27. https://doi.org/10.1016/j.ccm.2019.10.004.
Nasimi H, Madsen JS, Zedan AH, Malmendal A, Osther PJS, AlZahra’a Alatraktchi F,. Protein biomarker detection in prostate cancer: a comprehensive review of electrochemical biosensors. Sensors and Actuators Reports. 2023;6:100168. https://doi.org/10.1016/j.snr.2023.100168.
Roointan A, Ahmad Mir T, Ibrahim Wani S, Mati-ur-Rehman Hussain KK, Ahmed B, Abrahim S, Savardashtaki A, Gandomani G, Gandomani M, Chinnappan R, Akhtar MH. Early detection of lung cancer biomarkers through biosensor technology: a review. J Pharm Biomed Anal. 2019;164:93–103. https://doi.org/10.1016/j.jpba.2018.10.017.
Article CAS PubMed Google Scholar
Singh S, Gill AAS, Nlooto M, Karpoormath R. Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors. Biosens Bioelectron. 2019;137:213–21. https://doi.org/10.1016/j.bios.2019.03.065.
Article CAS PubMed Google Scholar
Bilal M, Javaid A, Amjad F, Youssif TA, Afzal S. An overview of prostate cancer (PCa) diagnosis: potential role of miRNAs. Transl Oncol. 2022;26:101542. https://doi.org/10.1016/j.tranon.2022.101542.
Article CAS PubMed PubMed Central Google Scholar
Wu Y, Wang Y, Huang Z, Liu Q. Recent advances in analysis technology for detection of prostate cancer biomarkers. Microchemical J. 2023;190:108740. https://doi.org/10.1016/j.microc.2023.108740.
Yang G, Xiao Z, Tang C, Deng Y, Huang H, He Z. Recent advances in biosensor for detection of lung cancer biomarkers. Biosens Bioelectron. 2019;141:111416. https://doi.org/10.1016/j.bios.2019.111416.
Article CAS PubMed Google Scholar
Kumar S, Shuaib M, AlAsmari AF, Alqahtani F, Gupta S. GNL3 and PA2G4 as prognostic biomarkers in prostate cancer. Cancers (Basel) 15;2023.
Akbari Nakhjavani S, Tokyay BK, Soylemez C, Sarabi MR, Yetisen AK, Tasoglu S. Biosensors for prostate cancer detection. Trends Biotechnol. 2023:1–20. https://doi.org/10.1016/j.tibtech.2023.04.001.
Bae J, Yang SH, Kim A, Kim HG. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer. Urol Oncol: Seminars Orig Invest. 2022;40:105.e1-105.e10. https://doi.org/10.1016/j.urolonc.2021.11.012.
Becerra MF, Atluri VS, Bhattu AS, Punnen S. Serum and urine biomarkers for detecting clinically significant prostate cancer. Urologic Oncology: Sem Orig Invest. 2021;39:686–90. https://doi.org/10.1016/j.urolonc.2020.02.018.
Chang EK, Gadzinski AJ, Nyame YA. Blood and urine biomarkers in prostate cancer: are we ready for reflex testing in men with an elevated prostate-specific antigen? Asian J Urol. 2021;8:343–53. https://doi.org/10.1016/j.ajur.2021.06.003.
Article PubMed PubMed Central Google Scholar
Wu D, Ni J, Beretov J, Cozzi P, Willcox M, Wasinger V, Walsh B, Graham P, Li Y. Urinary biomarkers in prostate cancer detection and monitoring progression. Crit Rev Oncol Hematol. 2017;118:15–26. https://doi.org/10.1016/j.critrevonc.2017.08.002.
Martignano F, Rossi L, Maugeri A, Gallà V, Conteduca V, De Giorgi U, Casadio V, Schepisi G. Urinary RNA-based biomarkers for prostate cancer detection. Clinica Chimica Acta. 2017;473:96–105. https://doi.org/10.1016/j.cca.2017.08.009.
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–74. https://doi.org/10.1038/nrc745.
Article CAS PubMed Google Scholar
Adamaki M, Zoumpourlis V. Prostate cancer biomarkers: from diagnosis to prognosis and precision-guided therapeutics. Pharmacol Ther. 2021;228:107932. https://doi.org/10.1016/j.pharmthera.2021.107932.
Article CAS PubMed Google Scholar
Hussain SH, Huertas CS, Mitchell A, Deman AL, Laurenceau E. Biosensors for circulating tumor cells (CTCs)-biomarker detection in lung and prostate cancer: trends and prospects. Biosens Bioelectron. 2022;197:113770. https://doi.org/10.1016/j.bios.2021.113770.
Article CAS PubMed Google Scholar
Osei E, Swanson S. A review of current clinical biomarkers for prostate cancer: towards personalised and targeted therapy. J Radiother Pract. 2022;21:277–86.
Huang H, Yang Y, Zhu Y, Chen H, Yang Y, Zhang L, Li W. Blood protein biomarkers in lung cancer. Cancer Lett. 2022;551:215886. https://doi.org/10.1016/j.canlet.2022.215886.
Article CAS PubMed Google Scholar
Liu R, Ye X, Cui T. Recent progress of biomarker detection sensors. Yosetsu Gakkai Ronbunshu/Quarterly Journal of the Japan Welding Society. 2020;38:. https://doi.org/10.2207/QJJWS.38.193.
Anand S, Samuel M, Ang C-S, Keerthikumar S, Mathivanan S. Label-based and label-free strategies for protein quantitation. In: Keerthikumar S, Mathivanan S (eds) Proteome Bioinformatics. New York. 2016. pp 31–43.
Joseph S, Harrington R, Walter D, Goldberg JD, Li X, Beck A, Litton T, Hirsch N, Blasberg J, Slomiany M, Rom W, Pass H, Donington J. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomarkers. 2012;12:177–84. https://doi.org/10.3233/CBM-130306.
Article CAS PubMed Google Scholar
Choi YE, Kwak JW, Park JW. Nanotechnology for early cancer detection. Sensors. 2010;10:428–55. https://doi.org/10.3390/s100100428.
Article CAS PubMed PubMed Central Google Scholar
Abayomi LA, Terry LA, White SF, Warner PJ. Development of a disposable pyruvate biosensor to determine pungency in onions (Allium cepa L.). Biosens Bioelectron. 2006;21:2176–9. https://doi.org/10.1016/j.bios.2005.10.024.
留言 (0)